Cargando…

Risk of hematologic malignancies after breast ductal carcinoma in situ treatment with ionizing radiation

The increased incidence of secondary hematologic malignancies (SHM) is a well-known, potentially fatal, complication after cancer treatment. It is unknown if patients with ductal carcinoma in situ (DCIS) of the breast treated with external beam radiotherapy (RT) and who survive long-term have increa...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Kang, Li, Zhuyue, Chen, Xingxing, Zhang, Jianjun, Xiong, Yongfu, Zhong, Guochao, Shi, Yang, Li, Qing, Zhang, Xiang, Li, Hongyuan, Xiang, Tingxiu, Foukakis, Theodoros, Radivoyevitch, Tomas, Ren, Guosheng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7925676/ https://www.ncbi.nlm.nih.gov/pubmed/33654083 http://dx.doi.org/10.1038/s41523-021-00228-6

Ejemplares similares

Integrated multi‐omics profiling of high‐grade estrogen receptor‐positive, HER2‐negative breast cancer
por: Wang, Kang, et al.
Publicado: (2021)

Smoking increases risks of all-cause and breast cancer specific mortality in breast cancer individuals: a dose-response meta-analysis of prospective cohort studies involving 39725 breast cancer cases
por: Wang, Kang, et al.
Publicado: (2016)

Cyclooxygenase-2 in tumor-associated macrophages promotes breast cancer cell survival by triggering a positive-feedback loop between macrophages and cancer cells
por: Li, Hongzhong, et al.
Publicado: (2015)

Different distribution of breast ductal carcinoma in situ, ductal carcinoma in situ with microinvasion, and invasion breast cancer
por: Wei, Zhang, et al.
Publicado: (2012)

Comparison of breast ductal carcinoma in situ and ductal carcinoma in situ with microinvasion, and analysis of axillary lymph node metastasis
por: Zhang, Geng, et al.
Publicado: (2020)

An insight into the invasion of breast ductal carcinoma in situ based on clinical, pathological and hematological data
por: Liu, Yanbiao, et al.
Publicado: (2022)

Characteristics, prognosis, risk factors, and management of recently diagnosed ductal carcinoma in situ with microinvasion
por: Li, Chunyan, et al.
Publicado: (2021)

KRAB zinc-finger protein 382 regulates epithelial-mesenchymal transition and functions as a tumor suppressor, but is silenced by CpG methylation in gastric cancer
por: Pei, Lijiao, et al.
Publicado: (2018)

Clinicopathological Characteristics of Breast Ductal Carcinoma In Situ: An Analysis of Chinese Population of 617 Patients
por: Mao, Guangmin, et al.
Publicado: (2021)

The tumor suppressor interferon regulatory factor 8 inhibits β-catenin signaling in breast cancers, but is frequently silenced by promoter methylation
por: Luo, Xinrong, et al.
Publicado: (2017)

Multiple Roles of Glycans in Hematological Malignancies
por: Pang, Xingchen, et al.
Publicado: (2018)

Ductal carcinoma in situ (DCIS)
por: Holland, R
Publicado: (2002)

Ductal Carcinoma In Situ of the Breast
por: Lee, Richard J., et al.
Publicado: (2012)

Breast Ductal Carcinoma In Situ
por: Sacchini, Virgilio, et al.
Publicado: (2012)

Long noncoding RNA LINC01089 predicts clinical prognosis and inhibits cell proliferation and invasion through the Wnt/β-catenin signaling pathway in breast cancer
por: Yuan, Hongfan, et al.
Publicado: (2019)

A case report of a patient with ductal carcinoma and a malignant phyllodes tumor in situ in 2 separate breasts
por: Li, Chen, et al.
Publicado: (2023)

Imaging of Noncalcified Ductal Carcinoma In Situ
por: Bragg, Ashley, et al.
Publicado: (2021)

Prognostic and predictive significance of tumor infiltrating lymphocytes for ductal carcinoma in situ
por: Xu, Fei-Fei, et al.
Publicado: (2021)

Genomic differences between pure ductal carcinoma in situ and synchronous ductal carcinoma in situ with invasive breast cancer
por: Kim, Shinn Young, et al.
Publicado: (2015)

Epigenetic silencing of the WNT antagonist Dickkopf 3 disrupts normal Wnt/β-catenin signalling and apoptosis regulation in breast cancer cells
por: Xiang, Tingxiu, et al.
Publicado: (2013)

Molecular subtypes predict second breast events of ductal carcinoma in situ after breast‐conserving surgery
por: Yang, Yilan, et al.
Publicado: (2022)

Evaluation of automated breast volume scanner for breast conservation surgery in ductal carcinoma in situ
por: Huang, Anqian, et al.
Publicado: (2016)

Multiple Microinvasion Foci in Ductal Carcinoma In Situ Is Associated With an Increased Risk of Recurrence and Worse Survival Outcome
por: Si, Jing, et al.
Publicado: (2020)

Insights into the transition of ductal carcinoma in situ to invasive ductal carcinoma: morphology, molecular portraits, and the tumor microenvironment
por: Chen, Weiling, et al.
Publicado: (2022)

Identification of biomarkers in ductal carcinoma in situ of the breast with microinvasion
por: Okumura, Yasuhiro, et al.
Publicado: (2008)

Genetic predisposition to ductal carcinoma in situ of the breast
por: Petridis, Christos, et al.
Publicado: (2016)

Ductal Carcinoma In Situ of the Breast: Perspectives on Tumor Subtype and Treatment
por: Liu, Yufei, et al.
Publicado: (2020)

Feasibility analysis of magnetic resonance imaging-based radiomics features for preoperative prediction of nuclear grading of ductal carcinoma in situ
por: Zhao, Meng-Ran, et al.
Publicado: (2023)

Immunohistochemical categorisation of ductal carcinoma in situ of the breast
por: Meijnen, P, et al.
Publicado: (2008)

Magnetic resonance imaging of ductal carcinoma in situ
por: Kuhl, C
Publicado: (2008)

Ductal carcinoma in situ (DCIS): are we overdetecting it?
por: Evans, A
Publicado: (2004)

Ductal carcinoma in situ (DCIS): are we overtreating it?
por: Dixon, JM
Publicado: (2004)

Status of Intraductal Therapy for Ductal Carcinoma in Situ
por: Flanagan, Meghan, et al.
Publicado: (2010)

DNA methylation in ductal carcinoma in situ of the breast
por: Pang, Jia-Min B, et al.
Publicado: (2013)

Tamoxifen Initiation After Ductal Carcinoma In Situ
por: Nichols, Hazel B., et al.
Publicado: (2016)

Ductal Carcinoma In Situ Biology, Biomarkers, and Diagnosis
por: Gorringe, Kylie L., et al.
Publicado: (2017)

Modeling Human Ductal Carcinoma In Situ in the Mouse
por: Behbod, Fariba, et al.
Publicado: (2018)

Ductal carcinoma in situ: to treat or not to treat, that is the question
por: van Seijen, Maartje, et al.
Publicado: (2019)

Potential biomarkers of ductal carcinoma in situ progression
por: Dettogni, Raquel Spinassé, et al.
Publicado: (2020)

Educational Case: Ductal Carcinoma In Situ (DCIS)
por: Komforti, Miglena K., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_3es4l5lg3pub3bt3gp9823jsi6